Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study Fisher, G. A., Wolin, E. M., Kunz, P. L., Liyanage, N., Mirakhur, B., Lowenthal, S., Pommier, R. F., Shaheen, M., Vinik, A. NATURE PUBLISHING GROUP. 2016: S457–S458

View details for Web of Science ID 000395764601483